UnitedHealth Group Beats Q1 2026 Expectations and Raises Full-Year Profit Outlook
UnitedHealth Group beat expectations, raised outlook, cut costs, and grew steadily—showing a solid turnaround and boosting investor confidence.
NOTRELOAD AI
Wall Street Backs Achieve Life Sciences: Cytisinicline Labeled 'Best-in-Class' Smoking Cessation Drug
Achieve Life Sciences gets Buy rating as its quit-smoking drug cytisinicline shows strong results; FDA decision due June 2026.
BBOT Scores FDA Fast Track for BBO-11818: A New Targeted Therapy for KRAS-Mutant Pancreatic Cancer
BBOT receives U.S. FDA Fast Track Designation for BBO-11818, its pan-KRAS inhibitor for advanced KRAS-mutant pancreatic cancer. Phase 1 data expected H2 2026.
Anthropic Secures 5 Gigawatts of Amazon AI Chips in $100 Billion Pact
Amazon invests up to $25B in Anthropic for Claude AI; Anthropic spends $100B on AWS to power big AI systems.
Fertitta Extends Exclusive Talks to Buy Caesars in $18 Billion Deal
Billionaire Tilman Fertitta is in exclusive talks to buy Caesars Entertainment for $18B. The deal would create a large, integrated casino and restaurant empire.
Arcus Biosciences Stops Phase 3 STAR-121 Lung Cancer Trial and Updates Gilead Partnership
Arcus stops a lung cancer trial early after poor outlook, ends a partner study, and gains more control as Gilead scales back the deal.